In a bid to prioritise more human-relevant models, the US Food and Drug Administration (FDA) has enforced a plan to phase out animal testing for monoclonal antibodies (mAbs) in the preclinical stage, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback